Search for European Projects

Over 40 European Projects Found

Searched on 125080 European Projects

 FINISHED 

Scaling up Safe Surgery for District and Rural Populations in Africa (SURG-Africa)

Start date: Jan 1, 2017, End date: Dec 31, 2020,

In sub-Saharan Africa 95% of the population has no access to surgical services. In this region surgery – a proven and often life-saving intervention – is only accessible to urban populations, with only one surgeon per 2.5 million people in rural areas. Emerging evidence demonstrates that major surgery can be undertaken safely and effectively at district hospitals, making it accessible to otherwise...
Read Project

 6

 FINISHED 

Development and Application of a New Class of Halogenated Reagents to Commercially Valuable Targets (Halo)

Start date: Jan 1, 2017, End date: Dec 31, 2020,

The aim of this project is to expand upon a newly discovered platform reaction by developing new routes to Active Pharmaceutical Ingredients (APIs) Tolterodine and Ezetimibe and other advanced intermediates for the manufacture of drugs (i.e. benzylic fluorides and alcohols). It is planned that this platform will serve to enhance the competitiveness of the European pharmaceutical manufacturing ind...
Read Project

 2

 FINISHED 

A Phase Ib/II study of MEK1/2 inhibitor PD-0325901 or MEK-162 with cMET inhibitor PF-02341066 in RASMT and RASWT (with aberrant c-MET) Colorectal Cancer Patients (MERCURIC)

Start date: Dec 1, 2013, End date: Nov 30, 2020,

Colorectal cancer (CRC) is the 3rd most common cancer in Europe, and with approximately 200,000 deaths per year, it remains the 2nd most common cause of cancer death. More than half of all CRC patients develop distant metastases and have 5-year overall survival (OS) of less than 5% because of ineffective treatments. Increased understanding of cancer biology, coupled with the implementation of “omi...
Read Project

 13

 FINISHED 

Water - Sustainable Point-Of-Use Treatment Technologies (WATERSPOUTT)

Start date: Jun 1, 2016, End date: May 31, 2020,

The WHO estimates that in 2015 in Africa ~156 million people relied on untreated sources for their drinking water. WATERSPOUTT will design, develop, pilot and field-test a range of, sustainable point-of-use solar disinfection (SODIS) technologies that will provide affordable access to safe water to remote and vulnerable communities in Africa and elsewhere. These novel large-volume water treatment ...
Read Project

 18

 FINISHED 

Endoplasmic Reticulum Stress in Health and Disease (TRAIN-ERS)

Start date: Oct 1, 2015, End date: Sep 30, 2019,

Endoplasmic reticulum (ER) stress is emerging as a common feature in the pathology of numerous diseases including cancer, neurodegenerative disorders, metabolic syndromes and inflammatory diseases. Thus ER stress represents a potential therapeutic intervention point to be exploited to develop novel therapies, diagnostic tools and markers for these diseases. However, exploitation is hampered by the...
Read Project

 12

 FINISHED 

An Investigation into the viability of employing lipoaspirate fluid as a cellular source in the production of small diameter tissue engineered vascular grafts (LAF-GRAFT)

Start date: Sep 1, 2016, End date: Aug 31, 2019,

Tissue engineered vascular grafts (TEVGs) hold great promise in the field of regenerative medicine and also possess the true potential to revolutionise the way in which clinicians treat the growing burden of cardiovascular disease. Treatment is achieved by incorporating an appropriate cell source onto a biodegradable scaffold and implanting the graft to bypass non-patent vascular segments. However...
Read Project

 1

 FINISHED 

Gender-related differences in expression of microRNAs in cystic fibrosis (GENDER-CF)

Start date: Sep 1, 2017, End date: Aug 31, 2019,

Cystic fibrosis (CF) is a hereditary disease involving a defective ion channel, resulting in altered epithelial cell function and consequent infective/inflammatory airway exacerbations. Progressive loss of lung function is the leading cause of death in CF patients. It is statistically noted that females have a disadvantage in survival and morbidity; this is commonly referred to as the CF gender ga...
Read Project

 1

 FINISHED 

Diabetes Reversing Implants with enhanced Viability and long-term Efficacy (DRIVE)

Start date: Jun 1, 2015, End date: May 31, 2019,

Diabetes mellitus is a chronic disease characterised by high blood glucose due to inadequate insulin production and/or insulin resistance which affects 382 million people worldwide. Pancreatic islet transplantation is an extremely promising cure for insulin-sensitive diabetes mellitus (ISDM), but side effects of lifelong systemic immunosuppressive therapy, short supply of donor islets and their po...
Read Project

 14

 FINISHED 

Adverse Immune Signatures and their Prevention in Corneal Transplantation (VISICORT)

Start date: Apr 1, 2014, End date: Mar 31, 2019,

"Immune system response is the most complex barrier to long-term success of tissue transplants/implants from allogeneic and bio-artificial sources. While newly developed tissue transplant procedures are not yet performed frequently enough for robust analysis of adverse immune responses in humans, corneal transplantation (CT) is a well-established allogeneic tissue transplant with >100,000 full- an...
Read Project

 12

 FINISHED 

Gene2Skin - Roadmap for advanced genetic engineering-based skin therapies (Gene2Skin)

Start date: Dec 1, 2015, End date: Nov 30, 2018,

Skin diseases and disorders are among the most common health problems worldwide and are associated with a considerable burden. It encompasses psychological, social and financial consequences not only on the patients, but also on their families and on society. Chronic and incurable skin diseases/disorders, such as bullous disorders, fibrosis and ulcers, are associated with significant morbidity in ...
Read Project

 3

 FINISHED 

Exploiting MELanoma disease comPLEXity to address European research training needs in translational cancer systems biology and cancer systems medicine (MEL-PLEX)

Start date: Dec 1, 2014, End date: Nov 30, 2018,

Novel treatment options and associated personalised, patient-tailored therapies need to be explored and developed for highly heterogeneous and chemotherapy resistant cancers, such as malignant melanoma. This can only be achieved by industry-academia collaborations in newly emerging, innovative research disciplines such as translational cancer systems biology and systems medicine. These disciplines...
Read Project

 11

 FINISHED 

MicroRNAs in the Pathogenesis, Treatment and Prevention of Epilepsy (EPIMIRNA)

Start date: Sep 1, 2013, End date: Aug 31, 2018,

Epilepsy is a major burden for patients and health systems worldwide. It is a common chronic neurological disorder affecting people of all ages, and the shortfall in existing treatments means that 30% of patients continue to suffer uncontrolled seizures. MicroRNAs (miRNA) are a recently-discovered, network-level layer of gene expression regulation that controls protein levels of entire signaling p...
Read Project

 19

 FINISHED 

Sustainable Polypeptide Nanoparticle Platform for Drug Delivery (NanoCap)

Start date: Apr 1, 2016, End date: Mar 31, 2018,

Biodegradable and biocompatible nanoparticles have high potential as viable carriers of active compounds in a broad range of applications for example for cosmetic ingredients as well as therapeutically active compounds such as vaccines, genes, drugs and other biomolecules (drug delivery). To advance current polymer nanoparticle technology we propose a novel nanomaterial platform based on synthetic...
Read Project

 1

 FINISHED 

Development of a chemotherapeutic gel for glioblastoma multiforme treatment (THERAGEL)

Start date: Apr 1, 2016, End date: Mar 31, 2018,

Advanced nanotechnology-based materials offer new solutions to the challenges associated with the non-specific delivery of therapeutics that leads to ineffective treatments, especially in oncology. Currently, both therapeutic and diagnostic molecules are administered systemically, increasing the likelihood of unwanted side effects. THERAGEL will develop a novel delivery system that enables selecti...
Read Project

 1

 FINISHED 

Bio-conjugatable and Bio-responsive Near Infrared Fluorochromes (NIR-BIO-FLU)

Start date: Mar 1, 2016, End date: Feb 28, 2018,

Near-infrared (NIR) fluorescence molecular imaging is a supra-discipline that enables visualisation of cellular function and real-time tracking of molecular processes in living organisms without perturbing them. If exploited to its maximum potential, NIR-fluorescence could have hugely positive impact for early stage diagnosis of diseases such as cancer, neurological and cardiovascular disease, th...
Read Project

 1

 FINISHED 

Macroporous Polymer Monoliths as a Low-Cost Bioanalytical Platform for Biopharmaceutical Glycoprotein (PoreSelect)

Start date: Feb 1, 2016, End date: Jan 31, 2018,

Glycoprotein therapeutics are widely seen as the next generation of drugs. 80% of new therapeutic drugs in phase 3 development are ‘biologics’. However, the early detection of critical glycosylation changes in biopharma pro-duction (i.e. in the drug producing cells) and the rapid and sensitive identification and separation of closely relat-ed protein-drug glycoforms presents an industry wide probl...
Read Project

 2

 FINISHED 

Advanced Materials for Cardiac Regeneration (AMCARE) (AMCARE)

Start date: Nov 1, 2013, End date: Oct 31, 2017,

The Advanced Materials for Cardiac Regeneration (AMCARE) consortium aims to establish a translational research program to develop truly restorative therapies for acute myocardial infarction repair (MI) by optimising cardiac progenitor cell (CPC) therapy using smart biomaterials and advanced drug delivery, and coupling these therapeutics with minimally-invasive surgical devices. Two distinct biomat...
Read Project

 10

 FINISHED 

WELCOME - Wearable Sensing and Smart Cloud Computing for Integrated Care to COPD Patients with Co-morbidities (WELCOME)

Start date: Nov 1, 2013, End date: Oct 31, 2017,

Description Innovative solutions for COPD multi-morbid patients To help Chronic Obstructive Pulmonary Disease (COPD) patients with comorbidities and to reduce the burden on our health systems, the WELCOME project aims to create innovative solutions such as an integrated care management tool and a ...
Read Project

 13

 FINISHED 

SYSTEMS-BASED VIEW OF MELANOMA PROGRESSION: TOWARDS NOVEL DIAGNOSTIC (AND THERAPEUTIC) APPLICATIONS (SYS-MEL)

Start date: Nov 1, 2013, End date: Oct 31, 2017,

Worldwide figures show that there were 160,000 incidences of melanoma in 2002, whilst 39,000 died from the disease. These upward trends are worrying, as malignant melanoma is one of the most difficult cancers to treat, due to its ability to spread quickly and its resistance to standard chemotherapeutic agents. In order to counteract this trend, targeted therapies that inhibit melanoma metastasis a...
Read Project

 7

 FINISHED 

EPISCHOOL – pokonajmy bariery razem!

Start date: Oct 1, 2015, End date: Sep 30, 2017,

The aim of the Project is to bring up a serious problem - epilepsy among children and teenagers at school. This problem touches not only persons with the disease, but also their teachers who not always are aware of the seriousness of the problem and are competent enough to cope with it. There are many examples of mistreating sick persons, such as forcing them to change school etc. By initializing ...
Read Project

 4

 FINISHED 

Higher education student and staff mobility project

Start date: Jun 1, 2016, End date: Sep 30, 2017,

This is a higher education student and staff mobility project, please consult the website of the organisation to obtain additional details.
Read Project

 1

 FINISHED 

Management of Hypotension In the Preterm Extremely Low Gestational Age Newborn (THE HIP TRIAL)

Start date: Oct 1, 2010, End date: Sep 30, 2017,

Assuming an annual birth rate of 10.25 births/1,000 population approximately 25,000 Extremely Low Gestational Age Newborns are born every year in the EU. Conservative figures estimate that approximately half of all these babies will develop low blood pressure and require treatment. However, no uniform criteria exist to define hypotension and the evidence to support our current management strategie...
Read Project

 17

 FINISHED 

Project for higher education student and staff mobility between Programme Countries and Partner Countries

Start date: Feb 1, 2016, End date: May 31, 2017,

This is a project for higher education student and staff mobility between Programme Countries and Partner Countries. Please consult the website of the organisation to obtain additional details.
Read Project

 1

 FINISHED 

Project for higher education student and staff mobility between Programme Countries and Partner Countries

Start date: Jun 1, 2015, End date: May 31, 2017,

This is a project for higher education student and staff mobility between Programme Countries and Partner Countries. Please consult the website of the organisation to obtain additional details.
Read Project

 1

 FINISHED 

Organo-Catalytic Nanoparticles for Organic Synthesis (OCN4OS)

Start date: Jun 1, 2015, End date: May 31, 2017,

The objective of this proposal is the development of a platform of recyclable organocatalysts that could be employed in the preparation of drugs or intermediates thereof. In order to achieve this objective the proposal brings together 3 partners with complementary skills: an expert in Phase Transfer Catalysis, Organo-Catalysis and synthesis (RCSI), an expert in development of DNA based catalysis a...
Read Project

 3

 FINISHED 

Temporally controlled delivery of vascular therapeutics from a regenerative template for diabetic wound healing (VascColl)

Start date: May 1, 2015, End date: Apr 30, 2017,

Having recently returned to the EU following Graduate (Massachusetts Institute of Technology) and Postdoctoral Training (Harvard University) in the USA, I hope to work as a MSCA Reintegration Fellow to tackle a devastating element of the escalating epidemic of diabetes. Specifically, the lack of synchronicity in diabetic wound-healing can lead to chronic diabetic foot ulcers (DFUs), with limb ampu...
Read Project

 1

 FINISHED 

miRNA-activated Scaffold Technologies for Cartilage Regeneration (miRaColl)

Start date: Sep 1, 2015, End date: Feb 28, 2017,

Adult articular cartilage has a limited capacity for repair so when damaged it can lead to joint degeneration and ultimately osteoarthritis. In our lab we have had significant success in enhancing tissue regeneration by functionalising collagen-based scaffolds for the delivery of therapeutic genes. In this project we propose to apply this concept for the delivery of microRNAs to promote enhanced c...
Read Project

 1

 FINISHED 

Protein biomarker for the prediction of response to endocrine treatment in breast cancer patients (EndoPredict)

Start date: Feb 1, 2013, End date: Jan 31, 2017,

Classical pathologic parameters have been used to inform adjuvant clinical treatment choices for early breast cancer patients. There remain a significant number of patients however, who despite a reportedly favourable prognostic profile, experience metastatic disease. Elucidation of the mechanisms of tumour adaptability and the identification of predictive markers of early recurrence is the basis...
Read Project

 2

 FINISHED 

Higher education student and staff mobility project

Start date: Jun 1, 2015, End date: Sep 30, 2016,

This is a higher education student and staff mobility project, please consult the website of the organisation to obtain additional details.
Read Project

 1

 FINISHED 

Clinical Officer Surgical Training in Africa (COST - Africa)

Start date: Apr 1, 2011, End date: Sep 30, 2016,

Obstetrical and abdominal emergencies, and trauma, much of it affecting children, represent a major and neglected part of Africa’s burden of disease. Countries cannot train and retain sufficient specialist surgeons (doctors) to address these priorities. We propose a surgical training intervention targeted at Clinical officers (COs), who are trained non-physician clinicians that form the backbone o...
Read Project

 4

 FINISHED 

A comprehensive analysis of microRNA-124 regulated gene networks and its role in epilepsy. (EpiMIRgen)

End date: Jul 1, 2016,

Evidence is emerging that rapid, profound and persisting changes in gene expression regulation and post-transcriptional regulation underlies the epileptogenic process. The current proposal builds on preliminary data which demonstrates that rapid reduction of a microRNA; miR-124, causes increased expression and activity of NRSF, a master-regulator of epileptogenesis. The current proposal will buil...
Read Project

 1

 FINISHED 

Predictive Genomic Biomarkers Methods for Combination Bevacizumab (Avastin) Therapy in Metastatic Colorectal Cancer (ANGIOPREDICT)

Start date: Feb 1, 2012, End date: Jan 31, 2016,

In recent years the treatment paradigm for metastatic colorectal cancer (mCRC) has evolved in complexity to include newly developed targeted therapeutics. In 2004 bevacizumab (bvz) [Avastin] became the first anti-angiogenic drug to be licensed in malignant disease, based on the results of a randomised trial in advanced metastatic colorectal cancer. Nevertheless, over the past six year period emerg...
Read Project

 12

 FINISHED 

TRANSLATIONAL RESEARCH AND PATIENT SAFETY IN EUROPE (TRANSFoRm)

Start date: Mar 1, 2010, End date: Nov 30, 2015,

TRANSFoRm will develop rigorous, generic methods for the integration of Primary Care clinical and research activities, to support patient safety and clinical research via:1.\tRich capture of clinical data, including symptoms and signs rather than just a single diagnosis. A generic, dynamic interface, integrated with electronic health records (EHR), will facilitate both diagnostic decision support ...
Read Project

 25

 FINISHED 

Epilepsy Pharmacogenomics: delivering biomarkers for clinical use (EpiPGX)

Start date: Nov 1, 2011, End date: Oct 31, 2015,

The purpose of the project is to identify genome-based biomarkers for use in clinical practice to individualise treatment of epilepsy, and stratify patients for clinical trials, aiming to avoid chronicity, prevent relapse and reduce adverse drug reactions (ADRs).The need for improved treatments in epilepsy is undoubted. Epilepsy is affects 50,000,000 people of all ages worldwide. Epilepsy is serio...
Read Project

 15

 FINISHED 

Higher education student and staff mobility project

Start date: Jun 1, 2014, End date: Sep 30, 2015,

This is a higher education student and staff mobility project, please consult the website of the organisation to obtain additional details.
Read Project

 1

 FINISHED 

Collagen scaffolds for bone regeneration: applied biomaterials, bioreactor and stem cell technology (COLLREGEN)

Start date: Nov 1, 2009, End date: Sep 30, 2015,

Regenerative medicine aims to regenerate damaged tissues by developing functional cell, tissue, and organ substitutes to repair, replace or enhance biological function in damaged tissues. The focus of this research programme is to develop bone graft substitute biomaterials and laboratory-engineered bone tissue for implantation in damaged sites. At a simplistic level, biological tissues consist of ...
Read Project

 1

 FINISHED 

European Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI)

Start date: May 1, 2010, End date: Apr 30, 2015,

The aim of EU-GEI is to identify the interactive genetic, clinical and environmental determinants involved in the development, severity and outcome of schizophrenia (EU-GEI, Schiz. Res. 2008; 102: 21-6). In order to identify these interactive determinants, EU-GEI will employ family-based, multidisciplinary research paradigms, which allow for the efficient assessment of gene-environment interaction...
Read Project

 27

 FINISHED 

Live Video-to-Video Supporting Interactive City Infrastructure (LiveCity)

Start date: Apr 1, 2012, End date: Jan 31, 2015,

The aim of LiveCity is to empower the citizens of a city to interact with each other in a more productive, efficient and socially useful way by using high quality video-to-video (v2v) over the Internet. Video-to-video can be used to save patients' lives, improve city administration, reduce fuel costs, reduce carbon footprint, enhance education and improve city experiences for tourists and cultural...
Read Project

 18

 FINISHED 

Apoptosis Modelling for Treatment Decisions in Colorectal Cancer (APO-DECIDE)

Start date: Nov 1, 2012, End date: Oct 31, 2014,

"With the arrival of new colorectal cancer (CRC) therapeutics targeting specific cell signalling pathways, such as anti-EGFR therapy, personalised cancer treatment is at the door step of clinical practise. This progress in drug development contrasts strikingly with current clinical practice, where decision making depends largely on clinical factors such as tumour staging and age of patient, with t...
Read Project

 7

 FINISHED 

European Research Ethics Committees’ Network (EURECNET)

Start date: Mar 1, 2011, End date: Aug 31, 2014,

EURECNET is a network that brings together national REC associations, networks or comparable initiatives but also other bodies relevant in the field of research involving human participants like National Ethics Councils and the European Commission’s ethical review system. Such a network forms the infrastructural basis to promote awareness of specific working practices of RECs across Europe, to enh...
Read Project

 22